Quantitative Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History

Quantitative Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $1.93 Million - $4.24 Million	-77,106 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $3.16 Million - $4.38 Million	77,106 New	77,106 $4.12 Million
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $881,400 - $1.38 Million	-24,201 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $950,131 - $1.28 Million	24,201 New	24,201 $1.17 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $8.88 Million - $12.6 Million	-245,234 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $4.61 Million - $9.12 Million	207,319 Added 546.8%	245,234 $8.83 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $284,853 - $343,485	12,215 Added 47.53%	37,915 $1.01 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $415,569 - $703,666	25,700 New	25,700 $690,000
Q4 2018 Feb 12, 2019	SELL	$14.32 - $22.92 $1.4 Million - $2.23 Million	-97,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $1.27 Million - $2.13 Million	97,500 New	97,500 $2.02 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.